Figure 2.
![Effect of danicopan on laboratory markers. Mean (and standard deviation [SD]) change from baseline (BL) for Hgb (primary end point) (A), reticulocytes (B), total bilirubin (C), direct bilirubin (D), LDH (E), and FACIT-Fatigue score (F). P values represent change from baseline to week 24.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/138/20/10.1182_blood.2021011388/7/bloodbld2021011388f2.png?Expires=1721517366&Signature=nZA6OQzpDfpWEv~pj5PSMEwuxoMfS7TJg8OLwt8WnZXvLhEq9y9lYsYAQ7L~Bq7foyIV72C6CiXz06ZQ5BSJQc2eHI-O33cQbFZrbvx0HqvF9pf1kgrmqrRUa~X1pqR1WXHfKA0CEALKtHoIRFS1vAj5ndnkBywgWWfjnjSzHCl3LkObfta~2qX1ZB9B2yJhTT20iUCMlrgVK~2Pd9r6j7VRVgODlq-08uIw9qJj0EAhD5wNuekDfvXoJDRaMKVFeBbGrAZ0NfDX~YpZ6ckwdJ6JokiDitk2065GMnMTXf-dtjd7QCLT8fYZp0yg5bi61csHCidPzrqDNR9Oe3lCmA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Effect of danicopan on laboratory markers. Mean (and standard deviation [SD]) change from baseline (BL) for Hgb (primary end point) (A), reticulocytes (B), total bilirubin (C), direct bilirubin (D), LDH (E), and FACIT-Fatigue score (F). P values represent change from baseline to week 24.